Výsledky vyhledávání

Studies of possible mechanisms for the effect of urokinase therapy in small cell carcinoma of the lung

Autor: V. A. Memoli, Leo R. Zacharski, J. A. Hunt, K. R. Meehan, L. H. Maurer, A. L. Howell, Jack Henkin, Sandra M. Rousseau

Publikováno v: Blood Coagulation & Fibrinolysis. 6:105-112

Urokinase-type plasminogen activator has been administered by other investigators to patients with small cell carcinoma of the lung (SCCL) in an attempt to induce lysis of fibrin that is known to exist in the connective tissue stroma of this tumour t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b7f6d09fb8474dcc38d89a8b5e8ac1
https://doi.org/10.1097/00001721-199504000-00003

Zobrazit plný text záznamu

Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study

Autor: L H Maurer, Michael C. Perry, Arthur T. Skarin, Robert W. Carey, Joseph Aisner, R Cooper, R Slawson, P Chahinian, Maria Goutsou, Mark R. Green

Publikováno v: Journal of Clinical Oncology. 10:1230-1236

PURPOSE In prior Cancer and Leukemia Group B (CALGB) studies, combined chemotherapy and thoracic irradiation was superior to chemotherapy alone in limited-disease (LD) small-cell lung cancer (SCLC). A combined modality pilot study was performed to te

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1037a62e38509f09125ded9ee4b7555d
https://doi.org/10.1200/jco.1992.10.8.1230

Zobrazit plný text záznamu

Socioeconomic status and cancer survival

Autor: David Cella, Peter M. Silberfarb, E J Orav, L H Maurer, Jimmie C. Holland, R Cooper, K W Lee, Michael C. Perry, Robert L. Comis, Alice B. Kornblith

Publikováno v: Journal of Clinical Oncology. 9:1500-1509

Survival data from eight Cancer and Leukemia Group B (CALGB) protocols were examined for patients with lung cancer (N = 961), multiple myeloma (N = 577), gastric cancer (N = 231), pancreatic cancer (N = 174), breast cancer (N = 87), and Hodgkin's dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aef29d2a9f567b1a826c481ed0ba9c0f
https://doi.org/10.1200/jco.1991.9.8.1500

Zobrazit plný text záznamu

Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma

Autor: S D, Conzen, P A, Kaufman, C, Arvizu, P, LeMarbre, L H, Maurer, L A, Mott, L E, Mills

Publikováno v: Cancer. 78(9)

Based on previous data demonstrating a potentially synergistic interaction between tamoxifen and cisplatin in metastatic melanoma therapy, a Phase II study was performed to assess the activity of tamoxifen, etoposide, mitoxantrone, and cisplatin (TEM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f22a4c118361513dbeb08be3be4a52ee
https://pubmed.ncbi.nlm.nih.gov/8909310

Zobrazit plný text záznamu

Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up

Autor: J F O'Donnell, S A DelPrete, S C Lattanzi, L. H. Maurer, Leila A. Mott, Marc S. Ernstoff, J Chertoff, Tor D. Tosteson, P J LeMarbre, R. J. Forcier

Publikováno v: Melanoma research. 5(5)

Metastatic melanoma has a grim prognosis. Response rates and survival of patients treated with combination chemotherapy are not superior to single-agent chemotherapy. This study seeks to evaluate the objective response rate and survival of patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23458a69f4a5dfa52b8db06dde21b410
https://pubmed.ncbi.nlm.nih.gov/8541728

Zobrazit plný text záznamu

Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests

Autor: Jen-I Mao, Melissa K. Schuster, Nancy Nutile-McMenemy, L. H. Maurer, Walter W. Noll, Hong Yu, Donald W. Bowden, V. A. Memoli, Feiyu Xue

Publikováno v: Human molecular genetics. 3(4)

Multiple endocrine neoplasia type 2A (MEN 2A) and familial medullary thyroid carcinoma (FMTC) are two closely related cancer syndromes inherited in an autosomal dominant manner. Mutations in the RET proto-oncogene were found in MEN 2A and FMTC famili

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a6cb8f32b671ec599bd247477c387f
https://pubmed.ncbi.nlm.nih.gov/7915165

Zobrazit plný text záznamu

A feasibility study of extended chemotherapy for locally advanced non-small cell lung cancer: a phase II trial of cancer and leukemia group B

Autor: Gerald H. Clamon, L H Maurer, Walter L. Eaton, M.R. Cooper, Mark R. Green, James E. Herndon, Julian G. Rosenman

Publikováno v: Cancer investigation. 12(3)

The purpose of this study was to determine the feasibility of additional chemotherapy beyond 5 weeks of vinblastine-cisplatin followed by radiation therapy for patients with stage III non-small cell lung cancer. In this randomized phase II trial, the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61932cd75282f23038d078a0b0878944
https://pubmed.ncbi.nlm.nih.gov/8187014

Zobrazit plný text záznamu

Continuous intratumoral infusion of methotrexate for recurrent glioblastoma: a pilot study

Autor: Jonathan D. Fratkin, D Nierenberg, Robert E. Harbaugh, G Scott, L H Maurer, Teddi M. Reeder, E Newman

Publikováno v: Neurosurgery. 28(5)

Five patients with documented recurrences of glioblastoma multiforme were given continuous infusions of methotrexate delivered intratumorally using implantable catheters and subcutaneous refillable pumps. A continuous infusion of methotrexate (1 mg/d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8455452387587455819f4b91983bd062
https://pubmed.ncbi.nlm.nih.gov/1652112

Zobrazit plný text záznamu

Reduction in size of a breast mass due to concurrent chemotherapy: pitfalls in mammographic follow-up

Autor: L H Maurer, Steven P. Poplack

Publikováno v: American Journal of Roentgenology. 167:392-393

D espite its proven clinical usefulness [I], periodic mammographic follow-up as an alternative to breast biopsy may be confounded by many factors. We report a patient with a suspicious mammographic abnormality that improved on a follow-up mammogram d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8122e49c6dce8cf3c3294e8a6006da29
https://doi.org/10.2214/ajr.167.2.8686613

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání